跳至主要内容
临床试验/NCT06659276
NCT06659276招募中不适用

Whole Body DWI Sequences As Compared with Standard FDG PET/CT in Patients with Simptomatic Multiple Myeloma

IRCCS Azienda Ospedaliero-Universitaria di Bologna1 个研究点 分布在 1 个国家目标入组 83 人开始时间: 2022年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
83
试验地点
1
主要终点
positivity rate

研究概览

简要总结

The primary objective is to evaluate the concordance of FDG PET/CT and total body DWI MRI sequences performed during staging and at the completion of therapy. Specifically, we will assess the positivity rates, both patient-based and lesion-based (total and by district), of the two methods during staging and at the completion of therapy. An interim analysis will be conducted comparing the two methods, followed by a final prognostic analysis.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • • Patients with symptomatic myeloma in the staging phase or with suspected symptomatic myeloma in the diagnostic phase
  • Patients who have signed the informed consent form

排除标准

  • Patients simultaneously affected by other neoplastic diseases or with a history of other neoplasms in the previous 5 years
  • Age < 18 years
  • Women who are breastfeeding or pregnant
  • Patients with metal implants or devices that constitute an absolute contraindication for MRI
  • Patients with severe claustrophobia
  • Patients with bone pain that prevents prolonged maintenance of the supine position

结局指标

主要结局

positivity rate

时间窗: 33 months

comparison per patient and per lesion between FDG PET CT and WB DWI

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Cristina Nanni

MD

IRCCS Azienda Ospedaliero-Universitaria di Bologna

研究点 (1)

Loading locations...

相似试验